FMI News
Archived Headlines
- 13 US IPOs planned for the week of Sep 23 09/23/13
- US IPO Recap: Twitter tweets its plans while eleven others set terms 09/16/13
- Cancer diagnostics company Foundation Medicine sets terms for $75 million IPO 09/12/13
- US IPO Recap: Six deals price, heavy deal flow continues into August 08/05/13
- Cancer diagnostics company Foundation Medicine files for a $86 million IPO 07/29/13
Aced the gene test: Invitae prices upsized IPO above range at $16
Invitae, which offers a broad suite of genetic tests as a single service at a low price, raised $102 million by offering 6.35 million shares at $16. The company originally planned to offer 5.35 million shares at a range of $13 to $15. At the new terms,...read more
Know your genome: Invitae sets terms for $75 million IPO
Invitae, which offers consumers a suite of genetic tests as a single service, announced terms for its IPO on Monday. The San Francisco, CA-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of...read more
US IPO Recap: Foundation Medicine soars, Chrysler revs up for an IPO
Last week saw high levels of activity in the IPO market, as eleven companies priced, making this month the first September to have 20 deals since September of 2000. Health care and technology companies continued to dominate the space, with nine of the...read more
Foundation Medicine prices upsized IPO at $18, above the range
Foundation Medicine, which offers diagnostic cancer analyses that provide patient specific data for physicians, raised $106 million by offering 5.9 million shares (up from an expected 5.0 million) at $18, above the range of $14 to $16. Foundation Medicine plans...read more